Annexin A1 on the Surface of Early Apoptotic Cells Suppresses CD8+ T Cell Immunity

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Weyd, Heiko ^a   Abeler Dörner, Lucie ^a,c   Linke, Björn ^a   Mahr, Andrea ^a,d   Jahndel, Veronika ^a   Pfrang, Sandra ^a   Schnölzer, Martina ^a   Falk, Christine S ^b   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d IMMATICS BIOTECHNOLOGIES GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; CELL PROTEIN; GAMMA INTERFERON; INTERLEUKIN 12; LIPOCORTIN 1; OVALBUMIN; PROTEIN PD L1; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOLECULAR MODEL; MOUSE; NONHUMAN; NORMAL HUMAN; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR REJECTION; ANIMAL; C57BL MOUSE; CELL CULTURE; IMMUNOLOGY; JURKAT CELL LINE; LYMPHOCYTE ACTIVATION;

MUS;

ANIMALS; ANNEXIN A1; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84876958875     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062449     Document Type: Article

References (56)

1. Cohen PL, Caricchio R (2004) Genetic models for the clearance of apoptotic cells. Rheum Dis Clin North Am 30: 473-86, viii.
2. Asano K, Miwa M, Miwa K, Hanayama R, Nagase H, et al. (2004) Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J Exp Med 200: 459-467.
3. Ravichandran KS, Lorenz U, (2007) Engulfment of apoptotic cells: signals for a good meal. Nature Reviews Immunology 7: 964-974.
4. Rock KL, Kono H, (2008) The inflammatory response to cell death. Annu Rev Pathol 3: 99-126.
5. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, et al. (1997) Immunosuppressive effects of apoptotic cells. Nature 390: 350-351.
6. Ferguson TA, Herndon J, Elzey B, Griffith TS, Schoenberger S, et al. (2002) Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8(+) T cells produce active immune unresponsiveness. J Immunol 168: 5589-5595.
7. Steinman RM, Turley S, Mellman I, Inaba K, (2000) The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 191: 411-416.
8. Huang FP, Platt N, Wykes M, Major JR, Powell TJ, et al. (2000) A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 191: 435-444.
9. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, et al. (2002) Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 196: 1627-1638.
10. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, et al. (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13: 54-61.
11. Green DR, Ferguson T, Zitvogel L, Kroemer G, (2009) Immunogenic and tolerogenic cell death. Nat Rev Immunol 9: 353-363.
12. Gerke V, Moss SE, (2002) Annexins: from structure to function. Physiol Rev 82: 331-371.
13. Gerke V, Creutz CE, Moss SE, (2005) ANNEXINS: LINKING Ca2+ SIGNALLING TO MEMBRANE DYNAMICS. Nat Rev Mol Cell Biol 6: 449-461.
14. Arur S, Uche UE, Rezaul K, Fong M, Scranton V, et al. (2003) Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell 4: 587-598.
15. Scannell M, Flanagan MB, deStefani A, Wynne KJ, Cagney G, et al. (2007) Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol 178: 4595-4605.
16. Blume KE, Soeroes S, Waibel M, Keppeler H, Wesselborg S, et al. (2009) Cell surface externalization of annexin A1 as a failsafe mechanism preventing inflammatory responses during secondary necrosis. J Immunol 183: 8138-8147.
17. Yang Y, Hutchinson P, Morand EF, (1999) Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis. Arthritis Rheum 42: 1538-1544.
18. Ernst S, Lange C, Wilbers A, Goebeler V, Gerke V, et al. (2004) An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. J Immunol 172: 7669-7676.
19. Pupjalis D, Goetsch J, Kottas DJ, Gerke V, Rescher U, (2011) Annexin A1 released from apoptotic cells acts through formyl peptide receptors to dampen inflammatory monocyte activation via JAK/STAT/SOCS signalling. EMBO Mol Med 3: 102-114.
20. Tomimori Y, Ikawa Y, Oyaizu N, (2000) Ultraviolet-irradiated apoptotic lymphocytes produce interleukin-10 by themselves. Immunol Lett 71: 49-54.
21. Chen W, Frank ME, Jin W, Wahl SM, (2001) TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14: 715-725.
22. Gonzalez N, Bensinger SJ, Hong C, Beceiro S, Bradley MN, et al. (2009) Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31: 245-258.
23. Verhoven B, Schlegel RA, Williamson P, (1995) Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 182: 1597-1601.
24. Surh CD, Sprent J, (1994) T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372: 100-103.
25. Liu K, Iyoda T, Saternus M, Kimura Y, Inaba K, et al. (2002) Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 196: 1091-1097.
26. Skoberne M, Somersan S, Almodovar W, Truong T, Petrova K, et al. (2006) The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function. Blood 108: 947-955.
27. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, et al. (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27: 3135-3142.
28. Morelli AE, Thomson AW, (2007) Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7: 610-621.
29. Ziegler-Heitbrock HW, (1995) Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm 45: 13-26.
30. D'Acquisto F, Merghani A, Lecona E, Rosignoli G, Raza K, et al. (2007) Annexin-1 modulates T-cell activation and differentiation. Blood 109: 1095-1102.
31. Mills KH, (2011) TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol 11: 807-822.
32. Waldner H, Collins M, Kuchroo VK, (2004) Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J Clin Invest 113: 990-997.
33. Miyake K, (2007) Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol 19: 3-10.
34. Medzhitov R, Preston-Hurlburt P, Janeway CA, (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
35. Jordan KR, McMahan RH, Oh JZ, Pipeling MR, Pardoll DM, et al. (2008) Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity. J Immunol 180: 188-197.
36. Li X, Kostareli E, Suffner J, Garbi N, Hammerling GJ, (2010) Efficient Treg depletion induces T-cell infiltration and rejection of large tumors. Eur J Immunol 40: 3325-3335.
37. Steinman RM, Nussenzweig MC, (2002) Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 99: 351-358.
38. Parnaik R, Raff MC, Scholes J, (2000) Differences between the clearance of apoptotic cells by professional and non-professional phagocytes. Curr Biol 10: 857-860.
39. Luckashenak N, Schroeder S, Endt K, Schmidt D, Mahnke K, et al. (2008) Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo. Immunity 28: 521-532.
40. Lutz MB, Kurts C, (2009) Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells. Eur J Immunol 39: 2325-2330.
41. Keir ME, Freeman GJ, Sharpe AH, (2007) PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues. J Immunol 179: 5064-5070.
42. Skurkovich S, Skurkovich B, (2005) Anticytokine therapy, especially anti-interferon-gamma, as a pathogenetic treatment in TH-1 autoimmune diseases. Ann N Y Acad Sci 1051: 684-700.
43. Wallet MA, Sen P, Flores RR, Wang Y, Yi Z, et al. (2008) MerTK is required for apoptotic cell-induced T cell tolerance. J Exp Med 205: 219-232.
44. Turley S, Poirot L, Hattori M, Benoist C, Mathis D, (2003) Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med 198: 1527-1537.
45. Levine B, Mizushima N, Virgin HW, (2011) Autophagy in immunity and inflammation. Nature 469: 323-335.
46. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE, (2009) Cell death. N Engl J Med 361: 1570-1583.
47. Majno G, Joris I, (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146: 3-15.
48. Zong WX, Thompson CB, (2006) Necrotic death as a cell fate. Genes Dev 20: 1-15.
49. Kono H, Rock KL, (2008) How dying cells alert the immune system to danger. Nat Rev Immunol 8: 279-289.
50. Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, et al. (2007) High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 81: 59-66.
51. Shi Y, Evans JE, Rock KL, (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521.
52. Pahl HL, (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866.
53. Natarajan S, Thomson AW, (2010) Tolerogenic dendritic cells and myeloid-derived suppressor cells: potential for regulation and therapy of liver auto- and alloimmunity. Immunobiology 215: 698-703.
54. Rondepierre F, Bouchon B, Papon J, Bonnet-Duquennoy M, Kintossou R, et al. (2009) Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination. Biochim Biophys Acta 1794: 61-69.
55. Lee AW, Truong T, Bickham K, Fonteneau JF, Larsson M, et al. (2002) A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy. Vaccine 20Suppl 4: A8-A22.
56. Garbi N, Tan P, Diehl AD, Chambers BJ, Ljunggren HG, et al. (2000) Impaired immune responses and altered peptide repertoire in tapasin-deficient mice. Nat Immunol 1: 234-238.